Editas Medicine, Inc. (EDIT) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 181.93M |
| Enterprise Value | 111.99M |
| P/E Ratio | -3.36 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 8.2 |
| Price/Book Ratio | 2.84 |
| Enterprise/Revenue | 4.66 |
| Enterprise/EBITDA | -3.12 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -1.57 |
| Operating Margin | -1.75 |
AD
Management Effectiveness
| Return On Assets | -0.31 |
| Return On Equity | -1.97 |
Income Statement
| Revenue | 40.52M |
| Revenue/Share | 0.39 |
| Gross Profit | 40.52M |
| EBITDA | -148.61M |
| Net Income | -160.06M |
| Diluted EPS | -1.8 |
Balance Sheet
| Total Cash | 211.65M |
| Total Cash/Share | 1.77 |
| Total Debt | 15.51M |
| Total Debt/Equity | 0.15 |
| Current Ratio | 3.19 |
| Book Value Per Share | 0.88 |
Price History
| 52-Week Change | -29.69 |
| 52-Week High | 3.94 |
| 52-Week Low | 1.66 |
| Moving Average 50 Days | 2.8 |
| Moving Average 200 Days | 2.66 |
Statistics
| Average Volume | 2.53M |
| Shares Outstanding | 153.58M |
| % Held by Institutions | 100.74 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
